Literature DB >> 15338800

Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia.

M M van der Eerden1, C S de Graaff, W Bronsveld, H M Jansen, W G Boersma.   

Abstract

The aim of the present study was to investigate whether the pneumonia severity index (PSI) could adequately predict the severity of community-acquired pneumonia (CAP) and could be used as a severity of illness classification system. Furthermore, reasons that may influence the decision to admit low risk patients were analysed. In a prospective study 260 patients with CAP were included. Stratification in five risk classes according to the PSI was compared with parameters that are closely related to severity of CAR A significant difference in severity parameters, such as length of stay (P < 0.001) and simplified acute physiologic score and acute physiologic and chronic health evaluation II score (P < 0.001) was found between the five risk classes. Furthermore, a positive British Thoracic Society (BTS) rule and modified BTS rule score was significantly more prevalent in the higher risk classes (P < 0.001). The patient population had an average 30-day mortality of 10% and a mean Intensive Care Unit (ICU) admission rate of 8%. The mortality rate and ICU admission rate significantly differed between the five risk classes (P < 0.001), in which the highest ICU admission rate (40.9%) and the highest mortality percentage (40.9%) were both found in risk class V. Several clinical factors (n = 64), such as an exacerbation of chronic obstructive pulmonary disease in 17 patients and clinical appearance of being ill in 16 patients, lack of improvement on outpatient antibiotic therapy (n = 15) and social circumstances (n = 3) were reasons that influenced the decision to hospitalise low risk patients (n = 82). The results show that the PSI adequately predicted the severity of CAP and can be used as a severity of illness classification in CAP. Clinical and social factors other than those mentioned in the PSI have to be considered when making the decision to hospitalise patients with CAP.

Entities:  

Mesh:

Year:  2004        PMID: 15338800     DOI: 10.1016/j.rmed.2004.02.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.

Authors:  James D Chalmers; Pallavi Mandal; Aran Singanayagam; Ahsan R Akram; Gourab Choudhury; Philip M Short; Adam T Hill
Journal:  Intensive Care Med       Date:  2011-06-10       Impact factor: 17.440

2.  Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; H M Jansen; W G Boersma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

Review 3.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

4.  Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients.

Authors:  Motoi Ugajin; Kenichi Yamaki; Natsuko Hirasawa; Takanori Kobayashi; Takeo Yagi
Journal:  Clin Interv Aging       Date:  2014-02-11       Impact factor: 4.458

Review 5.  Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Christophe Marti; Nicolas Garin; Olivier Grosgurin; Antoine Poncet; Christophe Combescure; Sebastian Carballo; Arnaud Perrier
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

6.  Adherence to therapeutic guidelines for patients with community-acquired pneumonia in Australian hospitals.

Authors:  Nr Adler; Hm Weber; I Gunadasa; Aj Hughes; Nd Friedman
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2014-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.